A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT

Inclusion Criteria

• •1. Patients diagnosed with RSV infection who have had a stem cell transplant.
• •2. Female patients must be of non-childbearing potential or have a negative pregnancy test prior to study start and be deemed not at risk of becoming pregnant. Females of non-childbearing potential are defined as women who have had a hysterectomy, bilateral oophorectomy, tubal ligation, or who have been post-menopausal for at least two years; or are considered to be sterile due to recent chemotherapy.
• •3. Aged between 18 and 65 years.
• •4. Patients who have given their written informed consent to participate in the study.
• •5. Patients who are willing and able to comply with the protocol and study procedures.